You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 21, 2024

Almatica Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Almatica
International Patents:53
US Patents:3
Tradenames:9
Ingredients:9
NDAs:9

Drugs and US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica ZOLPIDEM TARTRATE zolpidem tartrate CAPSULE;ORAL 215721-001 May 9, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Almatica LOREEV XR lorazepam CAPSULE, EXTENDED RELEASE;ORAL 214826-003 Aug 27, 2021 RX Yes Yes 8,999,393 ⤷  Try a Trial Y ⤷  Try a Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-005 Apr 18, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica VENLAFAXINE BESYLATE venlafaxine besylate TABLET, EXTENDED RELEASE;ORAL 215429-001 Jun 29, 2022 6,717,015 ⤷  Try a Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 6,340,475 ⤷  Try a Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 7,731,989 ⤷  Try a Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 6,488,962 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ALMATICA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 300 mg and 600 mg ➤ Subscribe 2011-10-31
Premature patent expirations for ALMATICA

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
⤷  Try a Trial ⤷  Try a Trial

Supplementary Protection Certificates for Almatica Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2236132 122015000006 Germany ⤷  Try a Trial PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
0503785 CA 2011 00026 Denmark ⤷  Try a Trial PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216
0347066 42/2002 Austria ⤷  Try a Trial PRODUCT NAME: ESCITALOPRAM UND DESSEN NICHT-TOXISCHE SAEUREADDITIONSSALZE; NAT. REGISTRATION NO/DATE: 1-24549, 1-24550, 1-24551, 1-24552 20020618; FIRST REGISTRATION: SE 17084, 17085, 17086,17087 20011207
2236132 CA 2015 00004 Denmark ⤷  Try a Trial PRODUCT NAME: ZOLPIDEM OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ZOLPIDEMTARTRAT; NAT. REG. NO/DATE: 47607 OG 47608 20120719; FIRST REG. NO/DATE: (B BE424286 OG BE424295 20120718
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.